Comments
Loading...

Cassava Sciences (SAVA) Stock Price, Quote, News & History

SAVANASDAQ
Logo brought to you by Benzinga Data
$2.05
-0.07-3.30%
At close: Jan 12, 4:00 PM EST
$2.10
-0.02-0.94%
Pre-Market: 7:02 AM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-83.77M
Investing Cash Flow (TTM)
-137.00K
Financing Cash Flow (TTM)
1.01M
Free Cash Flow (TTM)
-83.91M
Capital Expenditure (TTM)
-137.00K
Net Change in Cash (TTM)
-82.90M

Analyst Trends and Forecast

1
Oct 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$22.10M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.21
Earnings Yield % (TTM)
-108.29%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.69

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$106.08M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$2.05
Volume / Avg.
77.00 / 1.29M
Day Range
- - -
52 Wk Range
1.15 - 4.98
Market Cap
$101.45M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
35
Short Interest
15.1%
Days to Cover
5.77

About

Sector
Health Care
Industry
Pharmaceuticals
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SAVA
MDWD

FAQ

Q

How do I buy Cassava Sciences (SAVA) stock?

A

You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Cassava Sciences (SAVA) stock?

A

Cassava Sciences has a consensus price target of $39.00.

Q

What is the current price for Cassava Sciences (SAVA)?

A

The stock price for Cassava Sciences (NASDAQ: SAVA) is $2.1 last updated January 13, 2026 at 6:49 PM EST.

Q

Does Cassava Sciences (SAVA) pay a dividend?

A

There are no upcoming dividends for Cassava Sciences.

Q

When is Cassava Sciences (NASDAQ:SAVA) reporting earnings?

A

Cassava Sciences does not have any upcoming earnings scheduled.

Q

Is Cassava Sciences (SAVA) going to split?

A

There is no upcoming split for Cassava Sciences.

Q

What sector and industry does Cassava Sciences (SAVA) operate in?

A

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.